Alkermes plc (NASDAQ:ALKS) tinted gains of +0.09% (+0.03 points) to US$32.51. The volume of 0.79 Million shares climbed down over an trading activity of 1.03 Million shares. EPS ratio determined by looking at last 12 month figures is -0.76. Over the same time span, the stock marked US$71.22 as its best level and the lowest price reached was US$27.54. The corporation has a market cap of US$5.05 Billion.
Alkermes plc (NASDAQ:ALKS)’s earnings per share has been growing at a -47.1 percent rate over the past 5 year when average revenue increase was noted as 9.4 percent. The return on equity ratio or ROE stands at -11.9 percent while most common profitability ratio return on investment (ROI) was -9.5 percent. The company’s institutional ownership is monitored at 0 percent. The company’s net profit margin has achieved the current level of -13.2 percent and possesses 84.3 percent gross margin.
Daily Analyst Recommendations
A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 2 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 7 think it is Hold. Recently, analysts have updated the overall rating to 2.5. 4 analysts recommended Overweight these shares while 1 recommended Underweight, according to FactSet data.
MGIC Investment Corporation (NYSE:MTG) is worth US$4.02 Billion and has recently risen 0.09% to US$11.09. The latest exchange of 1.73 Million shares is below its average trading activity of 3.38 Million shares. The day began at US$10.99 but the price moved to US$10.81 at one point during the trading and finally capitulating to a session high of US$11.1. The stock tapped a 52-week high of US$16.21 while the mean 12-month price target for the shares is US$15.45.
Currently, the stock carries a price to earnings ratio of 6.35, a price to book ratio of 1.15, and a price to sales ratio of 3.62. For the past 5 years, the company’s revenue has grown -5%, while the company’s earnings per share has grown 17.9%. With an institutional ownership near 94.5%, it carries an earnings per share ratio of 1.75.
Inside Look At Analysts Reviews
Latest analyst recommendations could offer little help to investors. The stock is a Buy among 4 brokerage firms polled by Factset Research. At present, 2 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 1 analysts call it Underweight, while 5 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 2.